Ferring B.V.
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
35
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 16, 2026The maintenance fee for Pharmaceutical formulations (US 11,648,201) comes due Nov 16, 2026. Unpaid by May 17, 2027, it lapses early.
- 3 fees due Dec 6 to 20, 2026 · next Dec 6
- 2 fees due Jan 9 to 28, 2027 · next Jan 9
- 4 fees due Feb 1 to 25, 2027 · next Feb 1
- 4 fees due Mar 5 to 26, 2027 · next Mar 5
- 2 fees due Apr 15 to 22, 2027 · next Apr 15
- 2 fees due May 5 to 28, 2027 · next May 5
- 2 fees due Jun 24 to 30, 2027 · next Jun 24
- 2 fees due Jul 7 to 9, 2027 · next Jul 7
- 2 fees due Aug 4 to 16, 2027 · next Aug 4
- 3 fees due Sep 17 to 19, 2027 · next Sep 17
- 3 fees due Oct 21 to 26, 2027 · next Oct 21
Recent changes
- 2 terms have ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,858,992 | High drug load mesalazine sachet In force · From the USPTO record | In force | From the USPTO record | |
| US 7,795,314 | Protective Role of Semapimod in Necrotizing Enterocolitis In force · High confidence | In force | High confidence | |
| US 10,246,499 | Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis In force · Low confidence | In force | Low confidence | |
| US 8,361,273 | Polyurethane elastomers In force · From the USPTO record | In force | From the USPTO record | |
| US 10,105,445 | Hydrophilic polyurethane compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,802,148 | Microparticles and Method for Their Production In force · High confidence | In force | High confidence | |
| US 8,282,958 | Coating method In force · From the USPTO record | In force | From the USPTO record | |
| US D701,615 | Swirling apparatus In force · From the USPTO record | In force | From the USPTO record | |
| US 8,148,319 | Peptidic Vasopressin Receptor Agonists In force · High confidence | In force | High confidence | |
| US 8,361,272 | Polyurethane elastomers In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 112: 13 patents in force now held by others · 61 lapsed for an unpaid fee · 113 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
17 pending · 6 abandoned · 66 no status recorded